Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis

Figure 2 Heat shock protein 110 suppression by KNK437 under hyperthermic conditions. HSP110 expression in MKN45 cells was suppressed by KNK437 under hyperthermic conditions of 43 °C. A: Western blots of HSP110 and β-actin expression; B: Relative expression of HSP110 (normalized to β-actin). C: Schematic representation of experimental timeline. HSP110: Heat shock protein 110; HT: Heat treatment.